We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi will begin offering 30-day supplies of its insulin products to uninsured patients in the U.S. for $35 on July 1, the company announced Wednesday. Read More
Molecure said it is considering going back to its original plan, which was to develop OATD-01 for treatment of the inflammatory disease sarcoidosis. Read More
Moderna is also collaborating with the UK’s National Institute for Health Research on a phase 3 study investigating the company’s bivalent Omicron-containing booster candidate. Read More
The FDA granted ReViral’s investigational antiviral drug, sisunatovir, Fast Track designation in August 2020 for treatment of serious RSV infections. Read More